Simplex Trading’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,900
| Closed | -$30K | – | 11454 |
|
|
2022
Q2 | $30K | Buy |
20,900
+10,600
| +103% | +$7.79K | ﹤0.01% | 7180 |
|
|
2022
Q1 | $11K | Buy |
10,300
+900
| +10% | +$1.47K | ﹤0.01% | 8835 |
|
|
2021
Q4 | $23K | Buy |
9,400
+6,700
| +248% | +$26.3K | ﹤0.01% | 8236 |
|
|
2021
Q3 | $22K | Hold |
2,700
| – | – | ﹤0.01% | 8379 |
|
|
2021
Q2 | $22K | Buy |
2,700
+2,485
| +1,156% | +$21K | ﹤0.01% | 8520 |
|
|
2021
Q1 | $187K | Buy |
215
+113
| +111% | +$1.17K | ﹤0.01% | 4844 |
|
|
2020
Q4 | $110K | Buy |
102
+81
| +386% | +$999 | ﹤0.01% | 5364 |
|
|
2020
Q3 | $25K | Sell |
21
-121
| -85% | -$1.62K | ﹤0.01% | 6232 |
|
|
2020
Q2 | $228K | Sell |
142
-40
| -22% | -$698 | ﹤0.01% | 3848 |
|
|
2020
Q1 | $282K | Sell |
182
-360
| -66% | -$7.73K | ﹤0.01% | 3211 |
|
|
2019
Q4 | $1.33M | Buy |
542
+438
| +421% | +$6.5K | ﹤0.01% | 1825 |
|
|
2019
Q3 | $107K | Buy |
104
+86
| +478% | +$1.08K | ﹤0.01% | 4264 |
|
|
2019
Q2 | $22K | Sell |
18
-13
| -42% | -$167 | ﹤0.01% | 5547 |
|
|
2019
Q1 | $38K | Buy |
+31
| New | +$347 | ﹤0.01% | 5236 |
|
|
2018
Q4 | – | Sell |
-8
| Closed | -$8K | – | 8112 |
|
|
2018
Q3 | $8K | Buy |
8
+6
| +300% | +$68 | ﹤0.01% | 6562 |
|
|
2018
Q2 | $2K | Sell |
2
-3
| -60% | -$47 | ﹤0.01% | 7084 |
|
|
2018
Q1 | $3K | Sell |
5
-547
| -99% | -$9.24K | ﹤0.01% | 5105 |
|
|
2017
Q4 | $31K | Buy |
552
+397
| +256% | +$5.77K | ﹤0.01% | 2905 |
|
|
2017
Q3 | $31K | Buy |
155
+137
| +761% | +$2.09K | ﹤0.01% | 2767 |
|
|
2017
Q2 | $3K | Sell |
18
-260
| -94% | -$3.93K | ﹤0.01% | 5089 |
|
|
2017
Q1 | $84K | Buy |
278
+244
| +718% | +$3.25K | ﹤0.01% | 1909 |
|
|
2016
Q4 | $3K | Buy |
34
+12
| +55% | +$125 | ﹤0.01% | 4866 |
|
|
2016
Q3 | $5K | Buy |
+22
| New | +$201 | ﹤0.01% | 4353 |
|
|
2016
Q2 | – | Sell |
-18
| Closed | -$2K | – | 6669 |
|
|
2016
Q1 | $2K | Buy |
+18
| New | +$182 | ﹤0.01% | 4855 |
|
|
2015
Q4 | – | Sell |
-124
| Closed | -$13K | – | 6378 |
|
|
2015
Q3 | $13K | Buy |
+124
| New | +$2.5K | ﹤0.01% | 3226 |
|
Other funds holding EPZM
Simplex Trading's EPZM Position: Q4 2021 in Review
Simplex Trading sold out of Epizyme, Inc (EPZM) in Q4 2021, closing a stake of 7,717 shares — an estimated $30.3K sold.
Simplex Trading first reported a position in EPZM in Q4 2014 and held it in 21 quarters. The position peaked at $350K in Q1 2020. 132 funds tracked by Wall St. Rank hold EPZM as of Q4 2021.
- Simplex Trading reported no remaining Epizyme, Inc position as of Q4 2021 after selling out during the quarter.
- Simplex Trading sold 7,717 Epizyme, Inc shares in Q4 2021, an estimated $30.3K.
- Simplex Trading first reported a position in Epizyme, Inc in Q4 2014 and held it in 21 quarters.
- Simplex Trading's Epizyme, Inc position peaked at $350K in Q1 2020.
- 132 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2021.
Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.